Nuveen Asset Management’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,546
Closed -$153K 3193
2023
Q1
$153K Buy
15,546
+481
+3% +$4.73K ﹤0.01% 3020
2022
Q4
$144K Buy
+15,065
New +$144K ﹤0.01% 3077